Logo

Similar Products

Description

Dacotin 50mg Oxaliplatin represents a critical advancement in cancer chemotherapy, specifically developed for treating colorectal cancer and other gastrointestinal malignancies. Th...
Dacotin 50mg Oxaliplatin represents a critical advancement in cancer chemotherapy, specifically developed for treating colorectal cancer and other gastrointestinal malignancies. This platinum-based antineoplastic agent works by forming DNA cross-links that inhibit DNA synthesis and replication in rapidly dividing cancer cells. Manufactured under stringent quality control standards, each vial contains 50mg of pure Oxaliplatin powder for reconstitution, ensuring precise dosing and consistent therapeutic outcomes. The drug is packaged in sterile vials with tamper-evident seals to guarantee product integrity from manufacturing through administration.

This chemotherapy agent is extensively utilized in hospital oncology departments, cancer treatment centers, and specialized healthcare facilities worldwide. It serves as a fundamental component in FOLFOX regimens for colorectal cancer treatment, combining folinic acid, fluorouracil, and oxaliplatin. Medical oncologists also prescribe it for gastric cancer, pancreatic cancer, and other solid tumors where platinum-based chemotherapy demonstrates clinical efficacy. The product meets the demanding requirements of healthcare providers who prioritize treatment reliability, consistent supply continuity, and compliance with international pharmaceutical standards.

For healthcare distributors and institutional procurement teams, Oxaliplatin Dacotin 50mg delivers exceptional value through proven clinical efficacy and reliable performance. The product undergoes comprehensive quality testing at multiple manufacturing stages to ensure batch-to-batch consistency and therapeutic reliability. Its manufacturing process strictly adheres to Good Manufacturing Practices, providing buyers with confidence in product safety and regulatory compliance. The drug's established position in cancer treatment protocols makes it a trusted choice for medical facilities seeking effective chemotherapy solutions for patient care programs.

Key Features:
- High-purity 50mg Oxaliplatin formulation for precise chemotherapy dosing
- Manufactured under strict GMP compliance and quality assurance protocols
- Sterile vial packaging with tamper-evident seals for product integrity
- Batch-to-batch consistency ensured through rigorous quality control testing
- Stable shelf life with proper storage conditions maintained throughout distribution

Benefits:
- Precise dosing accuracy for consistent treatment outcomes in cancer therapy
- Regulatory compliance assurance meeting international pharmaceutical standards
- Guaranteed product safety and sterility through secure packaging systems
- Reliable therapeutic performance with consistent batch quality
- Maintained efficacy through controlled storage and distribution conditions

Specifications

Additional Information
Country of OriginIndia
CustomisableNo

Application

Dacotin 50mg Oxaliplatin serves as a cornerstone in combination chemotherapy regimens for advanced colorectal cancer treatment. Its mechanism inhibits DNA replication in cancer cells, effectively controlling tumor growth and metastasis. This makes it essential in modern oncology protocols for gastrointestinal cancers requiring systematic treatment approaches under medical supervision.

Medical professionals administer this chemotherapy drug through intravenous infusion in clinical environments with proper monitoring. It forms the basis of FOLFOX and similar combination therapies for both adjuvant and palliative cancer care. Proper handling and storage protocols ensure maintained stability and therapeutic efficacy throughout the product's shelf life and distribution chain.
- First-line treatment for stage III and IV colorectal cancer combined with fluorouracil
- Adjuvant therapy following surgical colon tumor resection to prevent recurrence
- Palliative care for metastatic gastrointestinal cancers improving survival rates
- Treatment protocol for advanced gastric cancer and pancreatic malignancies
- Hospital oncology department and cancer center chemotherapy infusion programs

Trade Details

Available StockIn stock
Sample AvailabilityNo

Payment Terms

Payment Terms
  • Custom Terms (manual entry)

Company Profile

Biogenix Pharma UK Limited, Maharashtra
Verified
IndiaMaharashtra, India
Manufacturer
Factory Details
Factory SizeBelow 1000 sqm
Annual Production Capacity0

Dacotin 50mg Oxaliplatin Chemotherapy Drug For Colorectal Cancer Treatment

Dacotin 50mg Oxaliplatin chemotherapy drug treats colorectal cancer and gastrointestinal malignancies with high-purity formulation for precise dosing in hospital oncology settings.

Min. Order Quantity: 1 units

Shipping

Shipping fee and delivery date to be negotiated. Contact supplier now for more details.

Biogenix Pharma UK Limited
Verified
IndiaMaharashtra, India
Manufacturer

More Products From Supplier

Related Products